Journal
JOURNAL OF BIOLOGICAL CHEMISTRY
Volume 292, Issue 50, Pages 20683-20693Publisher
AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
DOI: 10.1074/jbc.M117.809053
Keywords
endothelial cell; fibroblast; inflammation; interferon; microRNA (miRNA); PD-L1; immune checkpoint inhibitors; lymphatic endothelial cells; miR-155
Categories
Funding
- Medical Research Council New Investigator Research Grant [MR/L008505/1]
- Biotechnology and Biological Sciences Research Council (BBSRC) [BB/I007571/2]
- BBSRC Doctoral Training Program in Mechanistic Biology and its Strategic Application Grant [BB/J01113/1]
- BBSRC [BB/L003945/1, BB/I007571/1, BB/I007571/2, BB/L027755/1] Funding Source: UKRI
- MRC [MR/L008505/1] Funding Source: UKRI
- Biotechnology and Biological Sciences Research Council [BB/I007571/1, 1504182, BB/L027755/1, BB/L003945/1, BB/I007571/2] Funding Source: researchfish
- Cancer Research UK [12733] Funding Source: researchfish
- Medical Research Council [MR/L008505/1, 1365502] Funding Source: researchfish
Ask authors/readers for more resources
Programmed death ligand-1 (PD-L1) is a critical regulator of T cell function contributing to peripheral immune tolerance. Although it has been shown that posttranscriptional regulatory mechanisms control PD-L1 expression in cancer, it remains unknown whether such regulatory loops operate also in non-transformed cells. Here we studied PD-L1 expression in human dermal lymphatic endothelial cells (HDLECs), which play key roles in immunity and cancer. Treatment of HDLECs with the pro-inflammatory cytokines IFN- and TNF- synergistically up-regulated PD-L1 expression. IFN- and TNF- also affected expression of several microRNAs (miRNAs) that have the potential to suppress PD-L1 expression. The most highly up-regulated miRNA following IFN- and TNF- treatment in HDLECs was miR-155, which has a central role in the immune system and cancer. Induction of miR-155 was driven by TNF-, the effect of which was significantly enhanced by IFN-. The PD-L1 3-UTR contains two functional miR-155-binding sites. Endogenous miR-155 controlled the kinetics and maximal levels of PD-L1 induction upon IFN- and TNF- treatments. We obtained similar findings in dermal fibroblasts, demonstrating that the IFN-/TNF-/miR-155/PD-L1 pathway is not restricted to HDLECs. These results reveal miR-155 as a critical component of an inflammation-induced regulatory loop controlling PD-L1 expression in primary cells.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available